SCHEMBL1692014

SCHEMBL1692014

OC1=C(c2c(O)ccc3c2CCCC3)C2CCCCC2C=C1

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.36
BAD Q92934 1/20 0.36
CES1 P23141 1/20 0.33
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284960 0.74 BCL2L1 (0.58) BCL2L1BADCES1ACACBACACA
SCHEMBL17088054 0.74 CES1 (0.33) CES1
SCHEMBL16239399 0.71 BCL2L1 (0.52) BCL2L1BADCES1ACACBACACA
SCHEMBL21615634 0.70 ADRA1A (0.34) CES1
SCHEMBL14404128 0.70
SCHEMBL887399 0.70
SCHEMBL887276 0.70 GPR84 (0.31) CES1
SCHEMBL22147689 0.67
SCHEMBL13766657 0.67 BCL2L1 (0.48) BCL2L1BADCES1ACACBACACA
SCHEMBL15203248 0.67 BCL2L1 (0.48) BCL2L1BADCES1ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190352566-A1 CHIRAL COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME, OPTICALLY ANISOTROPIC BODY, AND LIQUID CRYSTAL DISPLAY DEVICE SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2019-11-21 US disclosed
US-10457870-B1 Chiral compound, liquid crystal composition containing the same, optically anisotropic body, and liquid crystal display device SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2019-10-29 US disclosed
US-8563786-B2 Method for producing optically active alcohol MITSUI CHEMICALS, INC. (JP) 2013-10-22 US disclosed
US-8563786-B2 Method for producing optically active alcohol MITSUI CHEMICALS, INC. (JP) 2013-10-22 US disclosed
US-8329930-B2 Aluminum complex and use thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2012-12-11 US disclosed
US-8329930-B2 Aluminum complex and use thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2012-12-11 US disclosed
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-04-12 US disclosed
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-04-12 US disclosed
EP-2412694-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL Mitsui Chemicals, Inc. (JP) 2012-02-01 EP disclosed
US-20110082308-A1 ALUMINUM COMPLEX AND USE THEREOF TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-04-07 US disclosed
US-20110082308-A1 ALUMINUM COMPLEX AND USE THEREOF TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL ADH1A, ADH1C, FHIT BCL2L1 2498/4885BAD 595/4885CES1 1840/4885
US-20110082308-A1 ALUMINUM COMPLEX AND USE THEREOF C9, ALOX12, ALOX5 BCL2L1 609/4885BAD 2205/4885CES1 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.